US FDA approves fewer small molecules but more biologics in 2009
09 February 2010
Nancy Faigen
Please Login to read the full article.
09 February 2010
Nancy Faigen
The US FDA's drug centre (CDER) had a productive year in 2009, with 25 approvals of novel products, up slightly from the 24 total of 2008. The list shows how much biologics have attracted the attention of top-tier pharma companies.
The 2009 figure included 19 new molecular entities...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Senator looks to 80/20 mantra to save PDUFA V in rancorous congressional climate
- US Capitol Capsule: Obama wants one-stop shop for patents, trade & small biz aid
- Weaker private equity in India for 2012, portfolios turning 'a la carte'
- US Capitol Capsule: Could another biosimilars fight be a brewin'?
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
